Amneal Intermediate Inc
NASDAQ:AMRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Amneal Intermediate Inc
NASDAQ:AMRX
|
US |
|
V
|
Viking Mines Ltd
F:AVI
|
AU |
|
I
|
Intesa Sanpaolo SpA
DUS:IES
|
IT |
|
Remala Abadi Tbk PT
IDX:DATA
|
ID |
|
H
|
Hershey Co
XMUN:HSY
|
US |
Intrinsic Value
Is AMRX undervalued or overvalued?
See the intrinsic value estimate for Amneal Intermediate Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
AMRX looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with AMRX’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Amneal Intermediate Does
Amneal Intermediate Inc. is a pharmaceutical company that develops, manufactures, and sells generic and specialty medicines. Its products include prescription drugs in forms such as tablets, capsules, injectable medicines, and other dosage types that treat common and chronic conditions. The company makes money mainly by selling these medicines to drug wholesalers, distributors, pharmacies, hospitals, and other healthcare providers.
- Headquarters
- United States of America US
- Employees
- 7 600
- IPO date
- Mar 16, 2009
Amneal Intermediate has no economic moat
Amneal Intermediate Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysisLatest Earnings Call
- EPS
- $0.27
- Expected
- $0.24
- Surprise
- +12.5%
- Stock, day of the call
- −3.1%
Revenue & Expenses Breakdown
Amneal Intermediate Inc
Earnings Waterfall
Amneal Intermediate Inc
The intrinsic value for Amneal Intermediate Inc (AMRX) under the Base Case is hidden USD.
Compared with the current market price of 19.655 USD, the stock appears hidden.